BiomX Secures Option to Acquire Defense Tech Company

BiomX ( (PHGE) ) just unveiled an update.

On March 31, 2026, BiomX Inc. entered into an Option and Undertaking Agreement with Mandragola Ltd. granting BiomX an exclusive, irrevocable option to acquire Mandragola’s full shareholding in DR. Frucht Systems Ltd., contingent on Mandragola first closing its own purchase of 60% of DFSL and obtaining Israel Innovation Authority approval for the ownership transfer. DFSL, which has previously received IIA grants for its anti-drone technology, provides LADAR-based security and surveillance systems deployed in both pilot and operational defense and transportation environments, and would become a majority-owned operating subsidiary of BiomX upon option exercise.

The option consideration is structured as a $100,000 cash payment, a $5 million unsecured convertible note, new Series D preferred shares, pre-funded warrants, and a five-year warrant, all tied to BiomX’s common stock at a $12 conversion or exercise price and subject in part to shareholder approval under NYSE American rules. The deal also includes an earnout-style bonus for Mandragola equal to 5% of DFSL’s annual revenues if they reach at least $25 million from fiscal 2027 onward, payable in cash or restricted stock, and Mandragola has agreed, upon closing, to extend a credit line to BiomX to fund DFSL’s business expansion and debt repayment, signaling a strategic move by BiomX to build a foothold in advanced security technologies.

The most recent analyst rating on (PHGE) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on BiomX stock, see the PHGE Stock Forecast page.

Spark’s Take on PHGE Stock

According to Spark, TipRanks’ AI Analyst, PHGE is a Neutral.

The score is driven down primarily by weak financial performance (no revenue, persistent cash burn, and negative equity) and bearish technical signals. Offsetting factors include some constructive clinical/regulatory updates from the latest earnings call, but near-term liquidity constraints and recent listing/going-concern concerns keep overall risk elevated.

To see Spark’s full report on PHGE stock, click here.

More about BiomX

BiomX Inc. is a Delaware corporation that, through this transaction, is positioning itself to enter the security and defense technology market via a majority-owned operating subsidiary. DR. Frucht Systems Ltd. (DFSL), the target company, develops proprietary LADAR-based detection systems combining laser sensing and AI to protect critical infrastructure through counter-drone, border security, wide-area surveillance, and rail and metro safety applications.

Average Trading Volume: 1,019,945

Technical Sentiment Signal: Sell

Current Market Cap: $5.98M

For a thorough assessment of PHGE stock, go to TipRanks’ Stock Analysis page.